U.S. Healthcare Services Stock News

NYSE:BMY
NYSE:BMYPharmaceuticals

How Bristol Myers Squibb’s Claude AI Deployment Across its Pipeline (BMY) Has Changed Its Investment Story

Earlier this month, Bristol Myers Squibb announced a wide-ranging partnership with Anthropic to deploy Claude AI across R&D, clinical development, manufacturing, commercial, and corporate functions to help accelerate drug development and operational workflows. This move, combined with Bristol Myers Squibb’s separate AI-focused collaboration with Tempus AI on clinical trial design, signals a broad push to integrate advanced data and AI tools throughout the company’s development...
NasdaqGS:ZD
NasdaqGS:ZDInteractive Media and Services

Is Ziff Davis’ (ZD) Strategic Review a Reset of Its Google-Exposed Portfolio Strategy?

Ziff Davis, Inc. recently completed participation in the 2026 Evercore TMT Global Conference in San Francisco, where it attended investor meetings without giving a formal presentation or webcast. Ahead of the conference, the company disclosed a broad strategic review exploring potential asset sales or spin-offs in response to operational challenges and negative organic growth linked to Google-related pressures. Next, we’ll examine how Ziff Davis’s newly announced strategic review and...
NYSE:DOCN
NYSE:DOCNIT

How Cloudways’ New Site Manager Adoption At DigitalOcean (DOCN) Has Changed Its Investment Story

Earlier in May 2026, DigitalOcean Holdings’ subsidiary Cloudways launched Cloudways Site Manager, an agency-grade WordPress management platform designed to unify workflows, automate maintenance, and monitor large website portfolios from a single interface. The launch has drawn very strong early engagement, with over 15,000 Public Preview applications and more than 4,000 users onboarded, highlighting growing interest in tailored cloud tools for agencies and developers. We’ll now explore how...
NasdaqGS:QURE
NasdaqGS:QUREBiotechs

Is uniQure’s (QURE) AMT-130 UK Push Quietly Rewriting Its Risk Profile and R&D Strategy?

In April 2026, uniQure announced plans to seek UK regulatory approval for AMT-130, its gene therapy for Huntington’s disease, supported by Phase 1/2 data indicating a very large slowing of disease progression at the high dose. The company also aims to meet the US FDA to discuss a potential Phase 3 trial, highlighting how AMT-130 is moving closer to a possible first-in-class treatment pathway for this rare neurodegenerative disorder. We’ll now examine how this move toward UK approval for...
NYSE:CTRI
NYSE:CTRIConstruction

Record Backlog and “Vision One Centuri” Plan Could Be A Game Changer For Centuri Holdings (CTRI)

Earlier this month, Centuri Holdings, Inc. filed a US$110.51 million shelf registration for 3,488,372 common shares and reported first-quarter 2026 results showing broad-based segment growth, record bookings of US$1.30 billion and a backlog expanding to US$6.50 billion. By pairing this record backlog with its newly launched “Vision One Centuri” plan through 2029, management signaled a clearer long-term framework for converting booked work into future operations. Next, we’ll assess how...
NasdaqGS:CHRD
NasdaqGS:CHRDOil and Gas

A Look At Chord Energy (CHRD) Valuation After Oil Price Pullback On Easing U.S Iran Tension Hopes

Chord Energy (CHRD) came under pressure after crude oil prices dropped on hopes of eased U.S. Iran tensions, reminding investors how closely the company’s share price tracks shifts in the commodity backdrop. See our latest analysis for Chord Energy. Despite the latest pullback on oil price headlines, Chord Energy’s 30-day share price return of 6.41% and 90-day share price return of 36.80% sit alongside a 1-year total shareholder return of 68.19%. This points to momentum that has cooled only...
NYSE:SG
NYSE:SGHospitality

A Look At Sweetgreen (SG) Valuation After JPMorgan Upgrade And Brand Refresh

Sweetgreen (SG) is back on investor radar after JPMorgan upgraded the stock to Overweight, citing confidence in new management, menu wraps aimed at everyday diners, and a broader brand refresh. See our latest analysis for Sweetgreen. The recent JPMorgan upgrade helped extend Sweetgreen's strong momentum. The 1 day share price return of 8.91% added to a 90 day share price return of 80.78%, even as the 1 year total shareholder return declined 23.65%, suggesting the rebound is still relatively...
NYSE:SPB
NYSE:SPBHousehold Products

Assessing Spectrum Brands (SPB) Valuation After Mixed Short Term Returns And 8.1% Upside Estimate

Spectrum Brands Holdings (SPB) has drawn investor attention after a recent move in its share price, with the stock closing at $78.35 and returns mixed across different recent time frames. See our latest analysis for Spectrum Brands Holdings. The recent 1-day share price return of 3.73% and 7-day share price return of 1.65% come after a period where the 30-day share price return declined 7.12%. At the same time, the year to date share price return of 30.50% and 1-year total shareholder return...
NYSE:ICE
NYSE:ICECapital Markets

Are ICE’s GPU Compute and Crypto-Linked Futures Expansions Altering The Investment Case For Intercontinental Exchange (ICE)?

In May 2026, Intercontinental Exchange, Inc. (ICE) expanded its rulebook for regulatory compliance and announced new Ornn-linked GPU compute futures, broader VaR-based margining for ERCOT power markets, and a crypto-partnered oil perpetual futures suite alongside record futures and options open interest. Together, these moves highlight ICE’s push to standardize pricing and risk management across emerging assets like GPU compute while deepening its role in traditional energy and multicurrency...
NasdaqGS:ENSG
NasdaqGS:ENSGHealthcare

Assessing Ensign Group (ENSG) Valuation After Revenue Growth And Earnings Miss

Ensign Group (ENSG) is back in focus after reporting revenue up 18.4% year over year, yet missing analysts’ estimates by 8.4%. This combination has cooled sentiment despite its established skilled nursing footprint. See our latest analysis for Ensign Group. The share price has pulled back recently, with a 30 day share price return of down 9.1% and a 90 day share price return of down 19.7%. However, the 1 year total shareholder return of 19.1% and 5 year total shareholder return of 108.9%...
NYSE:PM
NYSE:PMTobacco

Is It Too Late To Consider Philip Morris International (PM) After Its Strong Multi‑Year Rally?

Wondering if Philip Morris International at around US$188.99 is pricing in too much optimism or still leaving room on the table for value-focused investors. The stock is roughly flat over the past week with a 7-day return of a 0.3% decline, but sits on a 15.1% gain over 30 days, 17.9% year to date and 9.8% over 1 year, which puts recent moves in clear contrast to longer-term performance including a very large 3-year return and a 148.5% return over 5 years. Headlines around Philip Morris...
NYSE:GSL
NYSE:GSLShipping

Global Ship Lease (GSL) Net Margin At 54% Challenges Bearish Forecasts In Q1 2026 Results

Global Ship Lease (NYSE:GSL) has just posted Q1 2026 results with revenue of US$198.1 million and basic EPS of US$2.55, set against trailing 12 month revenue of US$760.1 million and EPS of US$10.51 that were accompanied by earnings growth of 18.3% and a net margin of 54% over the past year. Over recent quarters the company has seen revenue move from US$187.8 million and EPS of US$3.40 in Q1 2025 to US$198.1 million and EPS of US$2.55 in Q1 2026. The latest trailing year shows higher margin...
NasdaqGM:CRML
NasdaqGM:CRMLMetals and Mining

Assessing Critical Metals (CRML) Valuation After Long Term Tanbreez Offtake And Ownership Consolidation

Critical Metals (CRML) has drawn fresh attention after signing a 15-year rare earth concentrate offtake agreement with REalloys from its Tanbreez Project in southern Greenland, alongside government-approved ownership consolidation to 92.5%. See our latest analysis for Critical Metals. Alongside the new offtake deal and ownership consolidation, the recent shelf registration filing appears to have coincided with some cooling in momentum, with the stock down over the past month but still showing...
NasdaqGS:ASTS
NasdaqGS:ASTSTelecom

Assessing AST SpaceMobile (ASTS) Valuation After Carrier Joint Venture And FCC Authorization

AST SpaceMobile (ASTS) is back in focus after AT&T, T Mobile, and Verizon formed a joint venture for satellite direct to device coverage, with AST technology and fresh FCC approval drawing investor attention. See our latest analysis for AST SpaceMobile. The recent carrier joint venture, FCC approval and leveraged ETFs have come against a backdrop of strong momentum, with a 1 day share price return of 10.01%, a 30 day share price return of 38.56% and a very large 1 year total shareholder...
NYSE:ALLE
NYSE:ALLEBuilding

Is It Time To Reconsider Allegion (ALLE) After This Year’s Share Price Slide?

Wondering whether Allegion's current share price really reflects what you are getting as an investor? This article focuses on what the stock might be worth based on several valuation angles rather than just recent headlines. The stock most recently closed at US$130.43, with the share price up 3.8% over the past week, down 10.7% over the past month, down 18.9% year to date and down 6.4% over the past year. It is still 27.3% higher over three years and roughly flat over five years. Recent news...
NasdaqGS:OMCL
NasdaqGS:OMCLMedical Equipment

Omnicell (OMCL) Valuation Check After Earnings Beat And Upgraded Analyst Outlook

Recent quarterly results from Omnicell (OMCL) topped expectations for both revenue and profit, prompting analysts to lift their outlook and tighten consensus around higher earnings estimates and continued positive ratings. See our latest analysis for Omnicell. Omnicell’s share price has gained 18.84% over the past month and 12.26% over the past quarter. The year-to-date share price return is slightly down 1.62%, and the 1-year total shareholder return of 57.31% contrasts with longer term 3-...
NYSE:PSN
NYSE:PSNProfessional Services

Parsons’ D Line Role Highlights Transit Expertise And Valuation Opportunity

Los Angeles Metro has opened Section 1 of the D Line Subway Extension, a new segment of its heavy rail system. Parsons (NYSE:PSN) served as lead designer for this complex urban transit project. The extension adds new underground capacity to one of the largest public transit systems in the U.S. For investors following NYSE:PSN, this D Line milestone sits squarely in Parsons’ core business of engineering and program management for critical infrastructure. Large U.S. transit projects remain a...
NYSE:NU
NYSE:NUBanks

A Look At Nu Holdings (NU) Valuation After Record Q1 2026 Results And Latin America Expansion

Nu Holdings (NYSE:NU) just posted record Q1 2026 results, reporting quarterly revenue of US$5b and net income of US$871.4m, as its customer base exceeded 135 million across Latin America. See our latest analysis for Nu Holdings. Despite the strong Q1 print, Nu Holdings’ share price has been under pressure, with the stock down 12.3% on a 30-day share price return basis and 25.2% year to date. At the same time, the 3-year total shareholder return sits near 87.5%, suggesting long term momentum...
NYSE:OHI
NYSE:OHIHealth Care REITs

Will Omega Healthcare’s 2026 CEO‑CFO Succession Plan Reshape OHI’s Acquisition‑Driven Risk‑Reward Narrative?

Omega Healthcare Investors recently announced that long-serving CEO Taylor Pickett and CFO Bob Stephenson will retire in 2026, with President Matthew Gourmand set to become CEO and Chief Accounting Officer Neal Ballew stepping up as CFO under a multi-year succession plan. This planned leadership transition, supported by consulting agreements for the outgoing executives, signals an effort to maintain continuity while potentially refreshing how the REIT manages capital, acquisitions, and...
NYSE:RCL
NYSE:RCLHospitality

Is Record Demand And Mexico Setback Altering The Investment Case For Royal Caribbean (RCL)?

Earlier in 2026, Royal Caribbean Cruises reported a strong first quarter, with US$4.50 billion in revenue, 11% year-over-year growth, and earnings per share ahead of guidance amid record WAVE season bookings. At the same time, the company faced an environmental permitting setback for its planned Perfect Day Mexico destination, highlighting how regulatory reviews can complicate expansion even when demand and financial performance are robust. Next, we’ll examine how this combination of record...
NasdaqGS:SNPS
NasdaqGS:SNPSSoftware

Synopsys Quantum Push With Quantinuum Tests Next Stage Of Its Platform Story

Synopsys (NasdaqGS:SNPS) has partnered with Quantinuum to bring quantum computing into engineering simulation workflows. The collaboration focuses on embedding quantum capabilities directly into practical design tools used by engineers. The move introduces quantum methods to support higher fidelity and potentially more efficient simulations across complex design problems. For investors watching Synopsys at a share price of $524.74, this partnership highlights how the company is positioning...
NYSE:RBLX
NYSE:RBLXEntertainment

Is Roblox (RBLX) A Opportunity After Recent Share Price Weakness And DCF Upside?

Investors may be wondering whether Roblox at US$48.16 is starting to look interesting again, or if the stock still carries more excitement than value. The share price is up 12.4% over the last week, even though it is down 14.1% over the last month, 40.5% year to date, and 41.5% over the past year. These changes can influence how you think about both opportunity and risk. Recent headlines have focused on Roblox as a key player in online entertainment and user generated content. This keeps...
NYSE:ROK
NYSE:ROKElectrical

Rockwell’s In‑Cabinet Connectivity Upgrade Might Change The Case For Investing In Rockwell Automation (ROK)

In May 2026, Rockwell Automation expanded its EtherNet/IP In-cabinet Solution to support more motor control and protection devices, aiming to simplify wiring, enhance diagnostics, and improve real-time data access for manufacturers without requiring panel redesigns. This upgrade, together with Rockwell’s broader push into AI-driven energy optimization and smart manufacturing, underscores how richer in-panel connectivity is becoming central to more efficient, software-enabled industrial...
NYSE:MCK
NYSE:MCKHealthcare

McKesson Expands Oncology Data Reach As Investors Weigh Valuation Gap

Ontada, McKesson's oncology insights business, has entered a data partnership with Florida Cancer Specialists & Research Institute. The agreement integrates Florida Cancer Specialists' data into Ontada's platform, expanding its real world oncology dataset. The expanded data set is intended to support biopharma partners, research stakeholders, and community oncology providers. McKesson (NYSE:MCK), recently trading around $766.08, has recorded very large share price gains over the past 5...